SEC opens Teva bribery probe

The SEC has subpoenaed documents related to the company's operations in Latin America.

By GLOBES CORRESPONDENT
August 5, 2012 23:01
Teva Pharmaceutical plant is seen in Jerusalem

Teva 311. (photo credit: REUTERS/Ronen Zvulun)


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS